Effect of Dapagliflozin in Patients with Heart Failure: A Systematic Review and Meta-Analysis.

Ahmed E Ali Muhammad Sabry Mazroua Mariam ElSaban Nadia Najam Aditi S Kothari Taha Mansoor Tanya Amal Joanna Lee Rahul Kashyap

Published in: Global heart (2023)

Dapagliflozin reduces the risk of all-cause mortality, heart failure hospitalizations and cardiovascular death in a wide range of heart failure patients.

Keyphrases

heart failure
ejection fraction
left ventricular
atrial fibrillation
acute heart failure
cardiac resynchronization therapy